{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T05:11:10Z","timestamp":1738300270518,"version":"3.35.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["HORIZON-HLTH-2021-DISEASE-04 PROGRAM UNDER GRANT AGREEMENT N. 101057100 (UNDINE)"],"award-info":[{"award-number":["HORIZON-HLTH-2021-DISEASE-04 PROGRAM UNDER GRANT AGREEMENT N. 101057100 (UNDINE)"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00719-8","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:50:21Z","timestamp":1738223421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic diversity of the immunoglobulin heavy chain locus in cohorts of patients affected with SARS-CoV-2"],"prefix":"10.1186","volume":"19","author":[{"given":"Patrizia","family":"Malaspina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Jodice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Maria","family":"Ciminelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Biancolella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito Luigi","family":"Colona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Leonardis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Novelletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"5","key":"719_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"719_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41590-021-01030-z","volume":"23","author":"E Andreakos","year":"2022","unstructured":"Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nat Immunol. 2022;23(2):159\u201364.","journal-title":"Nat Immunol"},{"key":"719_CR3","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","volume":"383","author":"The Severe COVID-19 GWAS Group","year":"2020","unstructured":"The Severe COVID-19 GWAS Group. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383:1522\u201334.","journal-title":"N Engl J Med"},{"key":"719_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"Covid-Host Genetics Initiative","year":"2021","unstructured":"Covid-Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472\u20137.","journal-title":"Nature"},{"key":"719_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-biodatasci-020222-021705","volume":"6","author":"A Cobat","year":"2023","unstructured":"Cobat A, Zhang Q, Abel L, Casanova JL, Fellay J. Human genomics of COVID-19 pneumonia: contributions of rare and common variants. Annu Rev Biomed Data Sci. 2023;6:465\u201386.","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"6515","key":"719_CR6","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570.","journal-title":"Science"},{"issue":"62","key":"719_CR7","doi-asserted-by":"publisher","first-page":"eab14348","DOI":"10.1126\/sciimmunol.abl4348","volume":"6","author":"T Asano","year":"2021","unstructured":"Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021;6(62):eab14348.","journal-title":"Sci Immunol"},{"issue":"7902","key":"719_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","volume":"603","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Bastard P, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603(7902):587\u201398.","journal-title":"Nature"},{"issue":"1","key":"719_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40246-023-00515-2","volume":"17","author":"M Biancolella","year":"2023","unstructured":"Biancolella M, Colona VL, Luzzatto L, Watt JL, Mattiuz G, Conticello SG, et al. COVID-19 annual update: a narrative review. Hum Genom. 2023;17(1):68.","journal-title":"Hum Genom"},{"issue":"1","key":"719_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13073-023-01173-8","volume":"15","author":"D Matuozzo","year":"2023","unstructured":"Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med. 2023;15(1):22.","journal-title":"Genome Med"},{"issue":"1","key":"719_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","volume":"9","author":"L Wang","year":"2024","unstructured":"Wang L, Zhu Y, Zhang N, Xian Y, Tang Y, Ye J, et al. The multiple roles of interferon regulatory factor family in health and disease. Signal Transduct Target Ther. 2024;9(1):282.","journal-title":"Signal Transduct Target Ther"},{"issue":"6515","key":"719_CR12","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585.","journal-title":"Science"},{"issue":"62","key":"719_CR13","doi-asserted-by":"publisher","first-page":"eab14340","DOI":"10.1126\/sciimmunol.abl4340","volume":"6","author":"P Bastard","year":"2021","unstructured":"Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6(62):eab14340.","journal-title":"Sci Immunol"},{"issue":"8","key":"719_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41551-022-00925-y","volume":"6","author":"JJ Credle","year":"2022","unstructured":"Credle JJ, Gunn J, Sangkhapreecha P, Monaco DR, Zheng XA, Tsai H-J, et al. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. Nat Biomed Eng. 2022;6(8):992\u20131003.","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"719_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41590-024-01815-y","volume":"25","author":"JL Casanova","year":"2024","unstructured":"Casanova JL, Peel J, Donadieu J, Neehus AL, Puel A, Bastard P. The ouroboros of autoimmunity. Nat Immunol. 2024;25(5):743\u201354.","journal-title":"Nat Immunol"},{"issue":"2","key":"719_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184(2):476\u201388.","journal-title":"Cell"},{"key":"719_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"719_CR18","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1080\/22221751.2020.1762515","volume":"9","author":"B Sun","year":"2020","unstructured":"Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9(1):940\u20138.","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"719_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","volume":"17","author":"H Ma","year":"2020","unstructured":"Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, et al. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020;17(7):773\u20135.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"719_CR20","doi-asserted-by":"publisher","first-page":"e24031","DOI":"10.1016\/j.heliyon.2024.e24031","volume":"10","author":"K Esmat","year":"2024","unstructured":"Esmat K, Jamil B, Kheder RK, Kombe Kombe AJ, Zeng W, Ma H, et al. Immunoglobulin A response to SARS-CoV-2 infection and immunity. Heliyon. 2024;10(1):e24031.","journal-title":"Heliyon"},{"issue":"1","key":"719_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s40001-023-01282-5","volume":"28","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang J, Wu Y, Xu Y, Zheng J. SIgA in various pulmonary diseases. Eur J Med Res. 2023;28(1):299.","journal-title":"Eur J Med Res"},{"key":"719_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.molimm.2004.09.006","volume":"42","author":"MA Sepulveda","year":"2005","unstructured":"Sepulveda MA, Garrett FE, Price-Whelan A, Birshtein BK. Comparative analysis of human and mouse 3\u2019 Igh regulatory regions identifies distinctive structural features. Mol Immunol. 2005;42:605\u201315.","journal-title":"Mol Immunol"},{"key":"719_CR23","doi-asserted-by":"publisher","first-page":"147254","DOI":"10.1016\/j.gene.2023.147254","volume":"862","author":"R Cianci","year":"2023","unstructured":"Cianci R, Mancino G, Galli E, Serone E, Massoud R, D\u2019Addabbo P, et al. New insight of human-IgH 3\u2019regulatory regions in immunoglobulins switch. Gene. 2023;862:147254.","journal-title":"Gene"},{"issue":"4","key":"719_CR24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andr\u00e9 V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934\u201347.","journal-title":"Cell"},{"issue":"7\u20138","key":"719_CR25","first-page":"393","volume":"133","author":"LJ Ahrenfeldt","year":"2020","unstructured":"Ahrenfeldt LJ, Otavova M, Christensen K, Lindahl-Jacobsen R. Sex and age differences in COVID-19 mortality in Europe. Wien Klin Wochenschr. 2020;133(7\u20138):393\u20138.","journal-title":"Wien Klin Wochenschr"},{"issue":"9","key":"719_CR26","doi-asserted-by":"publisher","first-page":"bqaa127","DOI":"10.1210\/endocr\/bqaa127","volume":"161","author":"F Mauvais-Jarvis","year":"2020","unstructured":"Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology. 2020;161(9):bqaa127.","journal-title":"Endocrinology"},{"issue":"7837","key":"719_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315\u201320.","journal-title":"Nature"},{"issue":"10","key":"719_CR28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"719_CR29","doi-asserted-by":"publisher","first-page":"146698","DOI":"10.1016\/j.gene.2022.146698","volume":"838","author":"M Colucci","year":"2022","unstructured":"Colucci M, Frezza D, Gambassi G, De Vito F, Iaquinta A, Massaro MG, et al. Functional associations between polymorphic regions of the human 3\u2019IgH locus and COVID-19 disease. Gene. 2022;838:146698.","journal-title":"Gene"},{"issue":"2","key":"719_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/vim.2015.0104","volume":"29","author":"JL Hurwitz","year":"2016","unstructured":"Hurwitz JL, Penkert RR, Xu B, Fan Y, Partridge JF, Maul RW, et al. Hotspots for vitamin-steroid-thyroid hormone response elements within switch regions of immunoglobulin Heavy Chain loci predict a direct influence of vitamins and hormones on B Cell class switch recombination. Viral Immunol. 2016;29(2):132\u20136.","journal-title":"Viral Immunol"},{"issue":"7","key":"719_CR31","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/genes15070856","volume":"15","author":"C Jodice","year":"2024","unstructured":"Jodice C, Malaspina P, Ciminelli BM, Martinez-Labarga C, Biancolella M, Novelli G, et al. Variation of the 3\u2019RR1 HS1.2 enhancer and its genomic context. Genes (Basel). 2024;15(7):856.","journal-title":"Genes (Basel)"},{"issue":"7571","key":"719_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"The 1000 Genomes Project Consortium","year":"2015","unstructured":"The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374.","journal-title":"Nature"},{"issue":"3","key":"719_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1755-0998.2010.02847.x","volume":"10","author":"L Excoffier","year":"2010","unstructured":"Excoffier L, Lischer HE. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 2010;10(3):564\u20137.","journal-title":"Mol Ecol Resour"},{"issue":"4","key":"719_CR34","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978\u201389.","journal-title":"Am J Hum Genet"},{"key":"719_CR35","unstructured":"Erichson NB, Zheng P, Manohar K, Brunton SL, Kutz JN, Aravkin AY. Sparse Principal Component analysis via variable projection. arXiv. 2018;1804.00341."},{"issue":"10227","key":"719_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0140-6736(20)30526-2","volume":"395","author":"C Wenham","year":"2020","unstructured":"Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395(10227):846\u20138.","journal-title":"Lancet"},{"issue":"5","key":"719_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381.","journal-title":"Lancet Respir Med"},{"issue":"21","key":"719_CR38","doi-asserted-by":"publisher","first-page":"e2200413119","DOI":"10.1073\/pnas.2200413119","volume":"119","author":"J Manry","year":"2022","unstructured":"Manry J, Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, et al. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc Natl Acad Sci USA. 2022;119(21):e2200413119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"719_CR39","volume-title":"The history and geography of human genes","author":"LL Cavalli-Sforza","year":"1994","unstructured":"Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes. Princeton, N.J.: Princeton University Press; 1994."},{"issue":"8","key":"719_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrg2612","volume":"10","author":"TFC Mackay","year":"2009","unstructured":"Mackay TFC, Stone EA, Ayroles JF. The genetics of quantitative traits: challenges and prospects. Nat Rev Genet. 2009;10(8):565\u201377.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"719_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00251-024-01341-z","volume":"76","author":"D V\u00e1zquez-Coto","year":"2024","unstructured":"V\u00e1zquez-Coto D, Kimball C, Albaiceta GM, Amado-Rodr\u00edguez L, Garc\u00eda-Clemente M, G\u00f3mez J, et al. Immunoglobulin genes and severity of COVID-19. Immunogenetics. 2024;76(3):213\u20137.","journal-title":"Immunogenetics"},{"issue":"4","key":"719_CR42","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.chest.2023.10.032","volume":"165","author":"A Noguera-Castells","year":"2024","unstructured":"Noguera-Castells A, Parra J, Davalos V, Garc\u00eda-Prieto CA, Veselinova Y, P\u00e9rez-Mi\u00e9s B, et al. Epigenetic fingerprint of the SARS-CoV-2 infection in the lung of lethal COVID-19. Chest. 2024;165(4):820\u20134.","journal-title":"Chest"},{"issue":"4","key":"719_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41564-023-01344-8","volume":"8","author":"R Wang","year":"2023","unstructured":"Wang R, Lee JH, Kim J, Xiong F, Hasani LA, Shi Y, et al. SARS-CoV-2 restructures host chromatin architecture. Nat Microbiol. 2023;8(4):679\u201394.","journal-title":"Nat Microbiol"},{"issue":"1","key":"719_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12920-023-01707-4","volume":"16","author":"K Kocher","year":"2023","unstructured":"Kocher K, Bhattacharya S, Niforatos-Andescavage N, Almalvez M, Henderson D, Vilain E, et al. Genome-wide neonatal epigenetic changes associated with maternal exposure to the COVID-19 pandemic. BMC Med Genom. 2023;16(1):268.","journal-title":"BMC Med Genom"},{"key":"719_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2148-11-71","volume":"11","author":"P D\u2019Addabbo","year":"2011","unstructured":"D\u2019Addabbo P, Scascitelli M, Giambra V, Rocchi M, Frezza D. Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3\u2019Regulatory Region. BMC Evol Biol. 2011;11:71.","journal-title":"BMC Evol Biol"},{"key":"719_CR46","doi-asserted-by":"publisher","first-page":"108990","DOI":"10.1016\/j.clim.2022.108990","volume":"238","author":"S Hern\u00e1ndez-Do\u00f1o","year":"2022","unstructured":"Hern\u00e1ndez-Do\u00f1o S, S\u00e1nchez-Gonz\u00e1lez RA, Trujillo-Vizuet MG, Zamudio-Castellanos FY, Garc\u00eda-Silva R, Bulos-Rodr\u00edguez P, et al. Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas. Mexico Clin Immunol. 2022;238:108990.","journal-title":"Mexico Clin Immunol"},{"issue":"10","key":"719_CR47","doi-asserted-by":"publisher","first-page":"e29152","DOI":"10.1002\/jmv.29152","volume":"95","author":"S Matic","year":"2023","unstructured":"Matic S, Milovanovic D, Mijailovic Z, Djurdjevic P, Sazdanovic P, Stefanovic S, et al. Its all about IFN-\u03bb4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females. J Med Virol. 2023;95(10):e29152.","journal-title":"J Med Virol"},{"issue":"2","key":"719_CR48","doi-asserted-by":"publisher","first-page":"103333","DOI":"10.1016\/j.retram.2022.103333","volume":"70","author":"A David","year":"2022","unstructured":"David A, Parkinson N, Peacock TP, Pairo-Castineira E, Khanna T, Cobat A, et al. A common TMPRSS2 variant has a protective effect against severe COVID-19. Curr Res Transl Med. 2022;70(2):103333.","journal-title":"Curr Res Transl Med"},{"issue":"3","key":"719_CR49","doi-asserted-by":"publisher","first-page":"665","DOI":"10.17305\/bb.2023.9940","volume":"24","author":"JM Fragoso","year":"2024","unstructured":"Fragoso JM, Vargas-Alarc\u00f3n G, Mart\u00ednez-Flores \u00c1E, Montufar-Robles I, Barbosa-Cobos RE, Rojas-Velasco G, et al. ELANE rs17223045C\/T and rs3761007G\/A variants: protective factors against COVID-19. Biomol Biomed. 2024;24(3):665\u201372.","journal-title":"Biomol Biomed"},{"issue":"5","key":"719_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00705-024-06038-y","volume":"169","author":"FZE Yousfi","year":"2024","unstructured":"Yousfi FZE, Haroun AE, Nebhani C, Belayachi J, Askander O, Fahime EE, et al. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection. Arch Virol. 2024;169(5):109.","journal-title":"Arch Virol"},{"issue":"8","key":"719_CR51","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/jid.2008.40","volume":"128","author":"R Cianci","year":"2008","unstructured":"Cianci R, Giambra V, Mattioli C, Esposito M, Cammarota G, Scibilia G, et al. Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol. 2008;128(8):1920\u20134.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"719_CR52","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/ard.2010.147025","volume":"71","author":"D Frezza","year":"2012","unstructured":"Frezza D, Tolusso B, Giambra V, Gremese E, Marchini M, Nowik M, et al. Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus. Ann Rheum Dis. 2012;71(8):1309\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"719_CR53","first-page":"3618","volume":"20","author":"R Cianci","year":"2016","unstructured":"Cianci R, Lolli S, Pagliari D, Gambassi G, Frosali S, Marmo R, et al. The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn\u2019s disease: how the immune system can influence a multifactorial disease. Eur Rev Med Pharmacol Sci. 2016;20(17):3618\u201327.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"719_CR54","doi-asserted-by":"publisher","first-page":"637523","DOI":"10.1155\/2014\/637523","volume":"2014","author":"C Montesano","year":"2014","unstructured":"Montesano C, Giambra V, Frezza D, Palma P, Serone E, Gattinara GC, et al. HS1,2 Ig enhancer alleles association to AIDS progression in a pediatric cohort infected with a monophyletic HIV-strain. Biomed Res Int. 2014;2014:637523.","journal-title":"Biomed Res Int"},{"issue":"1","key":"719_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-micro-092123-022855","volume":"78","author":"JL Casanova","year":"2024","unstructured":"Casanova JL, Abel L. The microbe, the infection Enigma, and the host. Annu Rev Microbiol. 2024;78(1):103\u201324.","journal-title":"Annu Rev Microbiol"},{"issue":"17","key":"719_CR56","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1016\/j.cell.2022.07.004","volume":"185","author":"JL Casanova","year":"2022","unstructured":"Casanova JL, Abel L. From rare disorders of immunity to common determinants of infection: following the mechanistic thread. Cell. 2022;185(17):3086\u2013103.","journal-title":"Cell"},{"issue":"8","key":"719_CR57","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10875-020-00847-x","volume":"40","author":"S Okada","year":"2020","unstructured":"Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova JL, et al. Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy. J Clin Immunol. 2020;40(8):1065\u201381.","journal-title":"J Clin Immunol"},{"issue":"7","key":"719_CR58","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.immuni.2024.05.020","volume":"57","author":"L Abel","year":"2024","unstructured":"Abel L, Casanova JL. Human determinants of age-dependent patterns of death from infection. Immunity. 2024;57(7):1457\u201365.","journal-title":"Immunity"},{"issue":"10","key":"719_CR59","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/jmv.25860","volume":"92","author":"G Lippi","year":"2020","unstructured":"Lippi G, Mattiuzzi C, Sanch\u00eds-Gomar F, Henry BM. Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol. 2020;92(10):1759\u201360.","journal-title":"J Med Virol"},{"issue":"6","key":"719_CR60","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.4049\/jimmunol.1401174","volume":"193","author":"J Nikolich-\u017dugich","year":"2014","unstructured":"Nikolich-\u017dugich J. Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories. J Immunol. 2014;193(6):2622\u20139.","journal-title":"J Immunol"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00719-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:50:26Z","timestamp":1738223426000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00719-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00719-8","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Biological samples used in this study were collected according to the ethical procedures of the GEFACOVID2.0 research program active to the Tor Vergata Hospital. This program ensures that the work is carried out with the highest regard for ethical issues and concerning the rights, integrity, and privacy of patients. All consent, material\/information storage, and distribution procedures have been approved by the local Ethics Committees (CEI PTV protocol no. 50\/20). SARS\u2010CoV\u20102 positive patients who are offered participation in a research study sign an informed consent prepared ad hoc, which provides detailed information on the type of test, the implications of the genetic results, and the possible psychosocial implications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}